Merrill, J. T., Guthridge, J., Smith, M., June, J., Koumpouras, F., Machua, W., Askanase, A., Khosroshahi, A., Sheikh, S. Z., Rathi, G., Burington, B., Foster, P., Matijevic, M., Arora, S., Wang, X., Gao, M., Wax, S., James, J. A., & Zack, D. J. (2023). Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial. Arthritis & Rheumatology, 75(12), 2185–2194. Portico. https://doi.org/10.1002/art.42652
Columbia Affiliation:
Subjects:
Antibodies, Monoclonal
(MeSH)
Publication Type:
Article
Unique ID:
10.1002/art.42652
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus
Source Link: